Gsa Capital Partners LLP Cue Biopharma, Inc. Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 291,663 shares of CUE stock, worth $314,996. This represents 0.02% of its overall portfolio holdings.

Number of Shares

291,663

Previous 277,559 5.08%

Holding current value

$314,996

Previous $344,000 35.76%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$0.45 - $1.08 $6,346 - $15,232	14,104 Added 5.08%	291,663 $221,000
Q2 2024 Aug 15, 2024	BUY	$1.24 - $2.18 $84,889 - $149,240	68,459 Added 32.74%	277,559 $344,000
Q1 2024 May 03, 2024	BUY	$1.77 - $3.09 $345,411 - $603,007	195,148 Added 1398.71%	209,100 $395,000
Q4 2023 Feb 16, 2024	BUY	$1.72 - $3.1 $23,997 - $43,251	13,952 New	13,952 $36,000
Q2 2023 Aug 14, 2023	SELL	$3.11 - $4.91 $170,558 - $269,274	-54,842 Reduced 75.01%	18,269 $66,000
Q1 2023 May 12, 2023	SELL	$2.41 - $3.74 $277,624 - $430,836	-115,197 Reduced 61.17%	73,111 $261,000
Q4 2022 Feb 13, 2023	SELL	$2.39 - $3.95 $66,781 - $110,370	-27,942 Reduced 12.92%	188,308 $537,000
Q3 2022 Nov 14, 2022	BUY	$2.23 - $3.37 $193,082 - $291,788	86,584 Added 66.77%	216,250 $482,000
Q2 2022 Aug 09, 2022	BUY	$2.49 - $5.92 $82,426 - $195,969	33,103 Added 34.28%	129,666 $323,000
Q1 2022 May 11, 2022	SELL	$4.41 - $12.28 $14,345 - $39,946	-3,253 Reduced 3.26%	96,563 $471,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $237,953 - $391,111	-21,911 Reduced 18.0%	99,816 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$10.06 - $15.3 $938,909 - $1.43 Million	93,331 Added 328.68%	121,727 $1.77 Million
Q2 2021 Aug 05, 2021	BUY	$10.9 - $14.53 $171,457 - $228,556	15,730 Added 124.19%	28,396 $331,000
Q1 2021 May 10, 2021	SELL	$11.2 - $16.09 $578,267 - $830,742	-51,631 Reduced 80.3%	12,666 $155,000
Q4 2020 Feb 03, 2021	BUY	$11.12 - $16.4 $216,795 - $319,734	19,496 Added 43.52%	64,297 $804,000
Q3 2020 Nov 06, 2020	BUY	$15.05 - $23.54 $674,255 - $1.05 Million	44,801 New	44,801 $674,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Cue Biopharma, Inc. Transaction History